NCI and DOD Sign Pact on Clinical Trials: Others May Follow
نویسندگان
چکیده
منابع مشابه
Clinical trials referral resource. Current clinical trials of the Cancer Trials Support Unit (CTSU), an NCI pilot program.
The Cancer Trials Support Unit (CTSU) is a pilot program sponsored by the National Cancer Institute (NCI). The CTSU has two primary functions. It centralizes regulatory support for all adult Cooperative Group trials (phases IIII), thereby reducing duplication among Group members regarding credentialing, compliance with federal regulations, and institutional review board (IRB) activities. It als...
متن کاملEvaluation of Clinical Trials
In a number of important clinical issues such as evaluation of the efficacy or effectiveness of therapeutic or preventive interventions as well as for comparing the harms of interventions, randomized controlled trials (RCTs) provide the highest levels of evidence, either directly or indirectly. It is obvious that critical appraisal of these studies to assess their validity and precision is of p...
متن کاملQuestions and Answers: OvaCheck TM and NCI/FDA Ovarian Cancer Clinical Trials Using Proteomics Technology
The scientific goal of proteomics is to capture the information flow within the cell and the organism. Petricoin and Liotta have created new technologies to measure protein fingerprints. Potential benefits of clinical proteomics include developing individualized therapies using targeted treatments that have been predetermined to be effective for each patient; determining the toxic and beneficia...
متن کاملEvidence Based Medicine: Clinical Trials
Evidence based medicine is very important for success of modern medicine. It is the ongoing process of using the most reliable evidence from clinical studies, scientific understanding and medical practice to make the best possible medical choice for patients. Evidence based medicine is how medicine advances and how we get improvements in life expectancy and quality of life. It not only identifi...
متن کاملAn overview of the NCI precision medicine trials-NCI MATCH and MPACT.
The concept of oncogene addiction was first proposed by Weinstein in 2002, postulating that tumors rely on a single dominant mutation, the oncogenic "driver", for growth and survival. We have since come to realize that the genomic landscape of tumors is heterogeneous and more complex than previously thought. Advances in biotechnology and bioinformatics over the past decade have shifted treatmen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI: Journal of the National Cancer Institute
سال: 1996
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/88.7.404